Q1: Hypertransfusions

* Hypertransfusion
Per the beti-cel USPI, it is recommended that patients maintain a hemoglobin (Hb) ≥ 11 g/dL for at least 30 days prior to mobilization and apheresis, and 30 days prior to myeloablative conditioning. Any increase in number or cadence of pRBC transfusions used to achieve or maintain this Hb level are considered hypertransfusions in preparation for mobilization and conditioning.

Question 1: Was the recipient hypertransfused?

Indicate if the recipient was hypertransfused. If No, continue with Date of last iron chelation therapy dose given pre-infusion.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.